Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00014825
DRKS00014825
Completed
Not Applicable

Multicentre Non-interventional Study of Treatment Outcome in Heart Failure Patients with Hyperkalaemia under RAASi-treatment Receiving Veltassa in Routine Practice - CONTINUE-HF NIS

Vifor Pharma Deutschland GmbH0 sites22 target enrollmentJune 7, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsE87.5Hyperkalaemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
E87.5
Sponsor
Vifor Pharma Deutschland GmbH
Enrollment
22
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2018
End Date
December 31, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. 18 years or older
  • •2\. signed informed consent
  • •3\. heart failure with left ventricular ejection fraction less than 40%
  • •4\. with or without chronic renal insufficiency
  • •5\. therapy with inhibitors of the renin\-angiotensin\-aldosterone\-system (RAASi)
  • •6\. hyperkalemia (serum potassium values equal/higher than 5\.1 mmol/L at baseline that limits ability to maintain or increase the dose of RAASi
  • •7\. scheduled for treatment with Veltassa as per label

Exclusion Criteria

  • •1\. current dialysis or anticipated during study participation
  • •2\. type I diabetes mellitus
  • •3\. acute kidney injury
  • •4\. cancer with less than 12 months life expectancy
  • •5\. heart or kidney transplantation or anticipated during study participation
  • •6\. investigational medication currently, 21 days or 5 half\-lives prior to baseline
  • •7\. inability to consume Veltassa
  • •8\. severe medical condition currently or in the last 21 days prior baseline which could decrease study compliance or jeopardize the safety of the patient.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Non-interventional, multicentre study to see prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in India
CTRI/2018/08/015338AstraZeneca Pharma India Ltd
Completed
Not Applicable
A multicenter retrospective study on the treatment and the prognosis of descending necrotizing mediastinitisDescending necrotizing mediastinitis
JPRN-UMIN000035328Oita University, Department of Thoracic and Breast Surgery300
Not yet recruiting
Phase 1
A clinical study on the effect of Kidney-tonifying turbidimetry on renal Atherosclerosis
ITMCTR2000003571Affiliated Longhua Hospital of Shanghai University of Traditional Chinese Medicine
Recruiting
Phase 1
A clinical study on the effect of kidney-tonifying turbidimetry on atherosclerosisArteriosclerosis
ITMCTR2000003777Affiliated Longhua Hospital of Shanghai University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
A study investigating the effectiveness, safety and quality of life in participants with age related visual impairment (macular degeneration) who have switched to faricimab, under real world conditions in Germanyeovascular age related macular degeneration (nAMD)Eye Diseases
ISRCTN27514808Roche Pharma (Roche Germany)620